Conference Coverage

VIDEO: Dementia risk spikes in older veterans with sleep disorders, PTSD


 

AT AAIC 2014

References

COPENHAGEN – Older veterans who had sleep disturbances were at a 30% greater risk of developing dementia, according to a retrospective analysis of 200,000 medical records presented at the Alzheimer’s Association International Conference 2014.

And having posttraumatic stress disorder (PTSD) in addition to sleep disturbances put veterans at an 80% greater risk.

"As veterans are turning 65 and older, it’s important for us to understand who in that population is at an increased risk of developing dementia, so when we have that therapy or lifestyle intervention, we can intervene at that point," said Heather M. Snyder, Ph.D., director of medical and scientific operations at the Alzheimer’s Association. Dr. Snyder was not involved in the study.

For the study, researchers studied the records of veterans 55 years and older for 8 years. They found that almost 11% of the veterans with sleep disturbance developed dementia, compared with 9% of those without sleep disturbance, almost a 30% risk increase. The results were similar for veterans who had sleep apnea and nonapnea insomnia.

Meanwhile, researchers found no significant interaction between sleep disturbance and traumatic brain injury or PTSD, with regard to increased risk of dementia. However, veterans who had both PTSD and sleep disturbance had an 80% increased risk of developing dementia.

In a video interview, Dr. Kristine Yaffe, professor of psychiatry and neurology at the University of California, San Francisco, explains the study’s findings, shares practice pearls, and discusses the implications for younger veterans.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

nmiller@frontlinemedcom.com

On Twitter @naseemmiller

Recommended Reading

Alzheimer’s may be declining in U.S. and Germany
MDedge Neurology
VIDEO: New genetic research could identify Alzheimer’s therapy targets
MDedge Neurology
VIDEO: Don’t brush off subjective memory decline
MDedge Neurology
VIDEO: Investigative eye amyloid test shines a light on Alzheimer’s pathology
MDedge Neurology
Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial
MDedge Neurology
VIDEO: Consider cognitive function in elderly before surgery
MDedge Neurology
Lifestyle Intervention Improves Memory and Thinking in Older At-Risk Adults
MDedge Neurology
Many dementia patients have guns at home
MDedge Neurology
VIDEO: In patients with dementia, ask about guns at home
MDedge Neurology
Phase II Clinical Trial Results of Crenezumab for Alzheimer’s Disease
MDedge Neurology